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Abstract
In order to counter the common perception that molecular diagnostics are too complicated to work in low resource
settings, we have performed a difficult sample preparation and DNA amplification protocol using instrumentation designed
to be operated without wall or battery power. In this work we have combined a nearly electricity-free nucleic acid extraction
process with an electricity-free isothermal amplification assay to detect the presence of Clostridium difficile (C. difficile) DNA
in the stool of infected patients. We used helicase-dependent isothermal amplification (HDA) to amplify the DNA in a low-
cost, thermoplastic reaction chip heated with a pair of commercially available toe warmers, while using a simple Styrofoam
insulator. DNA was extracted from known positive and negative stool samples. The DNA extraction protocol utilized an air
pressure driven solid phase extraction device run using a standard bicycle pump. The simple heater setup required no
electricity or battery and was capable of maintaining the temperature at 65uC62uC for 55 min, suitable for repeatable HDA
amplification. Experiments were performed to explore the adaptability of the system for use in a range of ambient
conditions. When compared to a traditional centrifuge extraction protocol and a laboratory thermocycler, this disposable,
no power platform achieved approximately the same lower limit of detection (1.2561022 pg of C. difficile DNA) while
requiring much less raw material and a fraction of the lab infrastructure and cost. This proof of concept study could greatly
impact the accessibility of molecular assays for applications in global health.
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Introduction
Each year, over 9.5 million deaths are caused by infectious
diseases, nearly all occurring in developing nations [1]. Diseases
like diarrhea, malaria, and pneumonia are the leading causes of
death and disability, particularly in newborns and children [2,3,4].
By contrast, in the wealthiest nations, infectious diseases are
responsible for less than 5% of deaths [5]. In resource-poor
countries where electricity, financial support, and skilled work-
forces are inadequate, the increasingly sophisticated medical
technologies that allow rapid diagnosis of diseases are not widely
available. The scarcity of government resources in combination
with poor infrastructure hampers health care delivery, causing
diagnosis to take days or even months [6]. Consequently, effective
treatment is delayed resulting in an increase in both the mortality
rate and economic burden on society.
There is growing interest in the development of appropriate,
easy-to-adapt diagnostic technologies that can rapidly and
accurately identify pathogens [7,8,9] [10]. Microfluidics-enabled
testing is an option with the potential to improve global health and
the status of epidemic control. It can offer several advantages [11]:
1) lower cost, 2) energy efficiency, 3) capacity to perform complex
functions in a single device, 4) high sensitivity with small sample
volumes, 5) lightweight and portability for in-field testing, and 6)
relatively fast output. These unique characteristics make micro-
fluidics a natural fit for portable point-of-care (POC) diagnostic
systems [12,13,14,15]. However, the application of microfluidics
to medical diagnostic tools in developing countries is still evolving.
A common approach for making diagnostic technologies a feasible
option for the developing world is to make them completely self-
contained and/or purely disposable (e.g., immunochromato-
graphic strip) [15]. In addition to being simple and reliable,
instruments must be robust enough so that little maintenance is
needed, and operation can occur at a wide range (10 to 40uC) of
ambient temperatures [15,16]. Also, the device should be
operational within the infrastructure of a resource-limited envi-
ronment. Some diagnostic technologies have been developed and
applied in the developing world, these include lateral flow tests for
the diagnosis of diphtheria toxin and a number of sexually
transmitted infections, including HIV [17,18,19,20]. However,
due to several limitations, lateral flow assays can not provide
sufficient sensitivity and specificity required for accurate diagnos-
tics in many cases [15].
There is an emerging literature describing a new class of devices
that perform complicated biological manipulations with minimal
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instrumentation or instrumentation that requires limited or no
laboratory support [21,22,23]. Several simple devices have been
published that can be potentially applied in the developing world.
For example, LaBarre and his colleagues [24] validated a first
complete, non-instrumented nucleic acid amplification test
(NAAT) by using a CaO heat source for a loop-mediated
isothermal amplification (LAMP) assay. Also Wong et al. modified
a hand-powered egg beater into a centrifuge to isolate human
blood plasma from whole blood [6]. Several paper-based
microfluidic devices have been reported for use in bioanalysis
(e.g., level of glucose and proteins, pH, alkaline phosphatase)
[25,26,27,28].
One of the keys to preventing the spread of infectious diseases is
to minimize the assay time and reduce lag times in patient
treatment. A study by a panel of scientific experts in a variety low
resource settings and diseases found that rapid, affordable
molecular tests would be the most promising technology developed
by 2012 [29]. Nucleic acid-based assays have been successfully
implemented in recent years in many fields exploiting their rapid
and accurate analysis (e.g., medical diagnostics, forensics,
environmental analysis, and biodefense) [30,31,32,33,34]. Stan-
dard, tube based real-time polymerase chain reactions (qPCR) can
produce results within 30 min [35]. However, the need for precise
temperature control (i.e., use of a thermocycler), skilled personnel,
and very clean conditions makes it challenging to utilize qPCR in
many resource limited settings. Although a number of attempts
have been made to simplify and integrate such PCR-based assays,
methods published thus far generally require a thermocycler or an
alternate precise heat controller capable of functioning at a wide
range of temperatures. Hence, the development of a lower
temperature, isothermal amplification assay is an attractive option.
Here we describe a disposable DNA amplification platform
based on isothermal helicase dependent amplification (HDA). This
platform is capable of assaying DNA extracted from human stool
specimens infected with C. difficile. The extracted DNA was
obtained using a nucleic acid extraction protocol designed in our
lab (unpublished data). As shown in Figure 1, the system consists
of a low-cost thermoplastic microfluidic chip with three reaction
chambers, a pair of toe warmers as heaters, and a Styrofoam
passive temperature control system. The platform for DNA
amplification consists of readily available inexpensive components
and does not require a battery or electricity. Our design goal was
to make the device user friendly so that people with minimal
training are able to use it. In combination with emerging readout
technologies [26,36,37], the system has the potential to make a
great impact on disease diagnostic methodologies in resource-poor
settings.
Experimental Setup
Design of the Microfluidic Chip
The microfluidic chip was constructed from six layers of cyclic
olefin polymer (COP) film (Zeon Chemicals, Louisville, KY). The
microfluidic channels were prepared by cutting 188 mm thick
COP films using a Graft ROBO Pro CE5000-40 cutter plotter
(Graphtec America Inc., Irvine, CA) [38]. The two sheets with
inlet and outlet holes and the four sheets of cut film were stacked
and thermally bonded in a hot press (Heated Press 4386, Carver,
Wabash, IN) at 125uC for 20 min with 1.5 tons of pressure,
followed by 10 min of curing at 137uC without any pressure. The
inlet and outlet bridge channels are 188 mm high, 200 mm wide,
and 10 mm long. The reaction chamber (0.7562.5615 mm) is
able to hold an HDA reaction with a volume of 25 ml.
Toe Warmer and Styrofoam Cup as a Heater
A toe warmer (Heat Factory, Vista, CA) was used as a heat
source for the HDA reaction. It consists of a polypropylene bag
containing iron, salt, activated carbon, cellulose, and vermiculite.
When exposed to oxygen in the air, the iron powder oxidizes in an
exothermic reaction. The salt serves as a catalyst while the carbon
serves to disperse the heat. Vermiculite is added as an insulator to
maintain the generated heat, and the cellulose is filler. Since the
chemical components inside the commercially available toe
warmer are fixed, the duration of the reaction (as well as the
degree of heat generated) will mainly depend on air exposure and
humidity supply. Relative humidity (RH) is important, since water
on the surface of the iron particles can enhance the iron oxidation,
and therefore, generate more heat. When the environmental
humidity is high, more water vapour is available to promote
oxidation. The amount of vapor that interacts with iron particles is
dependent on the numbers of holes on the Styrofoam cup. The
more holes, the more vapor particles can be trapped to react with
iron. Therefore, by controlling numbers of holes on the Styrofoam
cups, the temperature and duration of the reaction can be
manipulated.
In our experiment, temperature control during a given
experiment was governed by the number of 1 mm diameter vent
holes, punched on opposite sides of a Styrofoam cup. To initiate
the HDA reaction process, first two toe warmers were activated by
the removal of their protective films. Next, the microfluidic
reaction chamber, preloaded with the reaction mixture, was
sandwiched between the warmers, and the entire assembly was
placed inside the cup. Lastly, the Styrofoam cup was capped with
another cup to complete the thermal chamber. The intra-cup
temperature was monitored using a thermocouple attached to the
microfluidic reaction chamber.
It is important to note that similar, and potentially more
consistent results might be achieved using phase change materials
[24,39] rather than exothermic heat packs. Our choice of heat
source was made solely based on convenience. This heat source
worked well in our setting and can be easily adapted to others as
described in the supplementary information.
Control DNA Extractions and ‘‘Gold Standard’’ Diagnosis
of C. difficile
To demonstrate the ability of our protocol to isolate and amplify
DNA from patient samples without wall power or battery support,
we chose an infectious diarrhea disease model. C. difficile-associated
diarrhea (CDAD) is the most common nosocomial infectious
diarrhea associated with prior antibiotic therapy. Two C. difficile
toxins, toxin A (tcdA) and toxin B (tcdB), have a cytopathic effect on
cell culture, and act synergistically to cause CDAD [40]. In this
work, a tissue culture cytotoxicity assay (Toxi-TitreTM Plate-HF
Cells, Trinity Biotech, Jamestown, NY) was used as the gold
standard assay to pre-determine the existence of C. difficile infection
in the stool samples. The discarded stool samples were obtained
under an exempt institutional review board (IRB) protocol by the
Microbiology Laboratory at Boston Medical Center and was
stored at 280uC prior to gold standard testing and/or DNA
extraction.
As a control DNA extraction process, we used a commercially
available extraction kit. A QIAamp DNA stool mini kit (Qiagen)
was used to extract stool genomic DNA following the manufac-
turer’s protocol. Briefly, 180 to 220 mg of stool was processed
including a 95uC lysis step, and eluted in a final volume of 200 ml.
The DNA concentration of the samples, as measured by
NanoDrop 2000 c spectrophotometer (Thermo Fisher, Wilming-
ton, DE), varied from 20 to 230 ng/ml, with the average
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concentration being 50 ng/ml. In this paper, 5 C. difficile positive
and 3 negative (as determined by both the gold standard
cytotoxicity test for tcdA and tcdB, and a tube based quantitative
PCR for tcdB) were tested in chip to demonstrate the efficiency of
our disposable DNA amplification platform.
Extraction of Patient Stool Samples using our Portable
System for Nucleic Acid Preparation (SNAP)
In order to demonstrate the concept of minimally instrumented
nucleic acid extraction, we also utilized a portable version of the
microfluidic nucleic acid extraction instrument and protocols
developed previously in our laboratory [41,42,43,44]. The
portable version of this extraction system is called SNAP-System
for Nucleic Acid Preparation. It is an air pressure driven
instrument powered by a standard bicycle pump. Stool samples
(180–220 mg) were premixed with 700 ml 5.5 M GuSCN (Sigma-
Aldrich, St. Louis, MO) lysis buffer for 30 min, spun at
14,000 rpm for 1 min. The supernatant was collected and
introduced into the porous polymer monolith (PPM) column for
selective nucleic acid capture. The PPM columns (Figure 2) were
housed in unaltered FinnTip Universal 250 ml filter-less pipette
tips (Thermo Fisher Scientific, Waltham, MA). These PPM
columns were fabricated as previously described [41,45] with
some modification. Briefly, the pre-polymer monomer solution
was prepared by mixing 125 ml Ethylene dimethacrylate (98%,
EDMA), 125 ml Butyl methacrylate (99%, BUMA) (both Sigma-
Aldrich, St. Louis, MO), 750 ml 1-dodecanol, and 8.0 mg
azobisisobutyronitrile (AIBN). 25 ml of this solution was pipetted
into each pipette tip. The pipette tips were incubated at 60uC for
overnight, followed by washing with 200 ml of methanol and
150 ml of 95% ethanol to remove excess unreacted material.
Finally, the solid phase extraction columns (SPEs) were dried in a
fixture under air pressure for two minutes at 2061.5% psi.
The SNAP (Figure 2) utilizes SPE to extract DNA from patient
stool samples in a self-contained fluidic system. The SNAP device
is a sealed fluidic system, which consists of four subsystems: a
reagent/sample input and mixer, a fluid buffering coil, an air
pressure accumulator, and a sample extraction cartridge. The
DNA extraction protocol run on SNAP is essentially a modified
Boom method [46] using the polymer monolith as the solid phase
instead of a silica resin. The reagent/sample input is composed of
five input ports designed for different buffers according to the
sample preparation protocol. In these experiments, only one port
is used, since only lysate and wash buffer (70% ethanol) were
required. Extractions were run with 2061.5% psi applied
pressure, maintained by an in-line regulator. This in-line regulator
steps the on-board pressure reservoir down to a constant 2061.5%
psi to maintain a constant pressure throughout the course of the
extraction. Regulator operating pressure is set through the use of
an external pressure gauge, and locked in place after calibration.
DNA from the stool samples was eluted in three fractions of 40 ml
nuclease free water. The extracted DNA was then amplified using
our disposable thermoplastic chip and a heating system. The
amplicons were examined via standard polyacrylamide gel
electrophoresis (PAGE).
Human GAPDH DNA Controls
To make sure that the extractions were successful and contained
DNA, PCR control reactions were performed using primers
designed to amplify the human GAPDH gene. These reactions
were expected to be positive even in patient samples that were not
infected with C. difficile, since all of the stool samples should
contain human DNA. Each 25 ml reaction mixture consisted of
12.5 ml SYBRH Green PCR Master mix (Applied Biosystems,
catalog #4309155), 0.1 mM GAPDH forward and reverse primers
(Applied Biosystems, catalog #402869), 7 ml nuclease free water,
and 5 ml DNA template. The thermal cycling conditions were as
follows: 1 cycle of 95uC for 10 min, followed by 40 cycles of 30 s at
95uC, and 1 min at 60uC.
HDA Amplification of C. difficile
In order to determine if the patient samples that tested positive
by the gold standard cytotoxicity test would also test positive for C.
difficile by HDA, an HDA reaction was set up using an IsoAmp III
Universal tHDA kit from BioHelix (Beverly, MA). C. difficile
genomic DNA from strain 630 (ATCCH, Manassas, VA) (0.5 ng/
Figure 1. Components of the disposable DNA amplification platform. (A) Polymer-based microfluidic chip with multiple reaction chambers,
a toe warmer, and Styrofoam cups; (B) Vent holes on the sides of the Styrofoam cup control the air supply to initiate and maintain the oxidation
reaction in the toe warmer; the number of holes controls the temperature of the reaction chamber.
doi:10.1371/journal.pone.0060059.g001
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ml) was used as a positive control. The genomic DNA isolated from
known negative patient stool samples was used as a check against
false positives.
Primers for HDA toxinA (tcdA) were designed using Primer-
QuestSM (Integrated DNA Technologies, Coralville, IA). The
specificity of the primers for the tcdA gene was verified using NCBI
BLAST (Accession #NC_009089.1) to assess their potential
homology to other human and/or microbial genes. The primers
used to amplify a 110 bp product were: C. difficile tcdA forward
primer (SpeI) 59-A CTA TAC TAG TGA TGT TGA TAT GCT
TCC AGG TAT TCA C-39 and reverse primer (AatII) 59-GAA
TGA CGT CTA TCA TTT CCC AAC GGT CTA GTC CAA
T-39. The primers contain SpeI and AatII restriction enzyme sites
to allow the generated HDA amplicons to be gel isolated, cloned
and sequenced to verify their identity. All the primers were
synthesized by Integrated DNA Technologies. HDA conditions
and reagent concentrations were optimized to obtain the final
parameters described herein. In brief, 2.5 ml of DNA template was
added to a 25 ml reaction mix containing 1X annealing buffer II,
40 mM NaCl, 4 mM MgSO4, 1.75 mM of IsoAmpH dNTP,
0.2 mM C. difficile tcdA forward primer, 0.1 mM reverse primer, and
12.75 ml nuclease free water.
Limit of Detection of On-chip and In-tube HDA
To determine the limit of detection for C. difficile genomic DNA
using our HDA assay, we spiked known concentrations of C.
difficile genomic DNA into DNA extracts from C. difficile negative
stool and performed HDA reactions. The negative stool sample
extract material was included to ensure that the simulated samples
contained the same (or similar) inhibitory molecules expected to be
present in patient samples. Each 25 ml reaction contained 5 ml of
DNA. Half of that (2.5 ml) was human specific DNA extract from
negative (both tcdA and tcdB negative by cytotoxicity assay) stool
extracted samples with an average concentration of 50 ng/ml. The
other half contained titrations of ATCC genomic C. difficile specific
DNA at known stock concentrations (effective masses ranging from
125 pg to 2.561023 pg). The master mix was then split to perform
both on-chip and in-tube HDA reactions to determine the
detection limit of each methods. The in-tube HDA reactions were
performed in triplicate using an ABI 2720 Thermocycler (Applied
Biosystems, Foster City, CA) at 65uC for 30 min. The on-chip
HDA reaction was performed using our toe warmer-Styrofoam
cup disposable temperature controller at 65uC62uC for 30 min.
Total incubation time is average of 45 min, which includes the
temperature ramps up to reach 65uC and 30 min incubation time.
The microfluidic chip consisted of 3 channels, two of which
contained the same concentration of C. difficile genomic DNA,
while the third contained no template and served as a negative
control. All experiments were repeated 2–3 times to confirm the
results.
Polyacrylamide Gel Analysis
PCR products generated from amplification of the human
GAPDH gene (226 bp) and HDA tcdA amplicons (110 bp) were
analyzed on a 12% non-denaturing polyacrylamide gel using MspI
digested pBR322 plasmid (New England Biolabs, Beverley, MA) as
a size marker. Gels were run at 75 V for 135 min then incubated
in 1X TBE buffer with 0.001X SYBR Green (Invitrogen,
Carlsbad, CA) at room temperature for 30 min. Finally gel photos
were taken under UV light using Molecular Imager PharosFXTM
System (Bio-Rad, Hercules, CA).
Validation of HDA toxinA Amplicons
To verify the identity of the HDA tcdA product, the 110 bp
amplicon was cloned and sequenced. Briefly, HDA products were
subjected to phenol chloroform extraction followed by ethanol
Figure 2. Picture of SNAP, the portable system for nucleic acid preparation.
doi:10.1371/journal.pone.0060059.g002
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precipitation and then digested with restriction enzymes SpeI and
AatII. Digested fragments were purified using PAGE and ligated
to the pGEMH-T Easy vector (Promega). Ligation was trans-
formed into Top10 chemically competent E.coli (Invitrogen). DNA
plasmids were isolated using Qiagen QIAprep spin mimiprep kit
(Qiagen). Two to four clones were selected for analysis and
subsequent sequencing with M13 reverse primer (sequence primer)
by Genewiz DNA Sequencing Center (Boston, MA).
Results
Temperature Stability of Disposable Heat Source
To examine the capability of our toe warmer-Styrofoam cup
system to maintain a constant temperature, activated toe warmers
were placed in the thermal chamber with vent holes (diameter of
1 mm made using a standard metal punch) on opposite sides of the
chamber as shown in Figure 1, and temperature readings were
recorded at thirty second intervals using a thermocouple attached
to the microfluidic chip reaction chamber. We first explored the
relationship between the number of vent holes (0, 15, 30, 45, 55
and fully opened with no vent holes or top cup) and the
temperature stability of the reaction chamber. As shown in
Figure 3(A) (external temperature was 20uC with ambient
humidity 2562.5%RH), the time it took the chamber temperature
to reach steady state was inversely proportional to the number of
vent holes. In the closed cup with no holes, the temperature
reached steady state after 50 min, while only 22 min was required
when the cup had 15 vent holes. A greater number of vent holes
causes the oxidation reaction inside toe-warmer to proceed faster
resulting in the generation of more heat per unit time. However, a
faster oxidation reaction also leads to a more rapid consumption of
the iron particles inside the toe warmer. Therefore, as shown in
Figure 3(B), we found the greater the number of vent holes
resulted in a corresponding decrease in the length of time quasi
steady state temperature was maintained. The open cup (without
vent holes and top cup) never reached a steady state temperature
and peaked near 80uC at approximately 30 min. In contrast, 55
vent holes resulted in a near steady state temperature of 65uC, the
optimum temperature of HDA reaction that was maintained for
greater than 55 min. These experiments were repeated at different
ambient temperatures (Figure S1).
It is important to qualify that these results are for our particular
setting and ambient conditions. We explored the stability of the
system further for different ambient conditions, and these results
are presented in more detail in the supplementary information.
Briefly, we looked at two additional external temperatures as well
as different humidity environments. As shown in Figures S2A
and S2B, the experiments above were run again in temperatures
of 30uC and 40uC with the humidity of 2562.5%RH. For these
conditions, 46 and 20 vent holes, respectively were needed in the
Styrofoam cup chamber to maintain a 65uC62.5uC for more than
30 min. In order to study the effect of humidity on our device, the
experiments were also run under temperatures of 30uC with the
humidity of 6561.5%RH and 8060.8%RH. As shown in
Figures S3A and S3B, 39 and 35 vent holes, respectively were
needed in the Styrofoam cup chamber to maintain a 65uC62.5uC,
and the duration of this quasi steady state temperature is longer
(more than 80 min) when compared with Figure S2A (30uC with
the humidity of 2562.5%RH). Similar trend (Figures S4A and
S4B) was found when the external temperature was 40uC with the
humidity of 5860.8%RH and 8260.4%RH, respectively. For
these conditions, 10 and 7 vent holes, respectively were needed in
the Styrofoam cup chamber to maintain a 65uC62.5uC for more
than 60 min. We also tested the effect of varying humidity
(Figures S5A and 5B) when the external temperature is 20uC.
Again, a similar trend was found, and 48 and 46 holes are required
respectively to keep the temperature 65uC62.5uC for HDA
reaction. Overall, as humidity increases, fewer holes are required
and the duration of steady state temperature is longer.
Microfluidic Channel HDA
The manufacturer’s protocol recommended conditions for
HDA in-tube reactions is 65uC for 90 min. We repeated HDA
in-tube reactions using our optimized HDA amplification recipe
for 30, 60, and 90 min. time points, and found that a 30 min.
reaction was sufficient to reliably amplify the C. difficile tcdA
product (Figure S2). We first tested our toe warmer-Styrofoam
cup platform by amplifying purified ATCC C. difficile genomic
DNA (0.5 ng/ml). HDA reaction products were subjected to
polyacrylamide gel analysis and then cloned and sequenced as
described above to confirm their identity. The sequencing results
showed that these were true positive products. The ATCC C.
Figure 3. Temperature stability inside the Styrofoam cups with different numbers of holes punched on both sides. Temperature was
measured on a microfluidic reaction chamber sandwiched between two toe warmers. The platform is able to maintain the temperature at 65uC62uC
for more than 55 min.
doi:10.1371/journal.pone.0060059.g003
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difficile genomic DNA was used as a positive control for each on-
chip HDA reaction.
The next step was to use the platform to amplify DNA extracted
from human stool samples. The concern here is that the ratio of
target DNA to total DNA extracted may be extremely low. In
addition, inhibitors present in extracted stool samples may
negatively affect the HDA assay, by decreasing its sensitivity and
or specificity. Extracted stool DNAs from 8 patients (5 positive, 3
negative by the cytotoxicity assay and confirmed with qPCR) were
amplified in the disposable platform. For each three channel chip,
one channel was used for the test patient sample, one for the
positive control (commercial C. difficile DNA (0.5 ng/ml)), and one
for the negative control. As shown in Figure 4(A), polyacrylamide
gel analysis confirms that the toe warmer-Styrofoam cup platform
was effective at amplifying the appropriate tcdA products from both
stool DNA samples (#1, #2, #3, #4 and #5) and commercial
genomic DNA, but no product was generated in the negative
control reaction. In addition, as shown in Figure 4(B), none of
the 3 cytotoxicity negative stool samples (#6, #7 & #8) amplified
a product. The HDA on-chip reaction results were consistent in
each case with the corresponding reaction in-tube (Figure 4(C))
and cytotoxicity assay. To confirm the integrity of the genomic
DNA in the C. difficile negative stool samples, PCR was performed
to detect the human GAPDH gene. ATCC C. difficile genomic
DNA and nuclease free water were used as templates for negative
control reactions. The expected human GAPDH gene products
(Figure 4(C)) were detected in both negative and positive stool
samples. Reactions containing the ATCC C. difficile genomic DNA
and nuclease free water were negative. This confirms that negative
stool samples contained intact genomic DNA.
SNAP Extracted DNA
The patient stool DNA extracted via SNAP was collected and
amplified using our disposable thermoplastic chip and heating
system. As shown in Figure 5, none of the negative stool samples
(#6,#8) amplified a product, while the positive stool samples (#1,
#2, #4) was effectively amplified. This result is consistent with the
result of DNA extracted by Qiagen kit. And further demonstrate
that the sample preparation and amplification can be done non-
lab instrumented.
Limit of Detection
The performance of the on-chip and in-tube HDA reactions
varied in terms of the lower limit of detection. From Figure 6, the
on-chip reaction using the disposable platform produced a lower
limit of detection just above 1.2561022 pg. As listed in Table 1,
for each concentration of ATCC C. difficile genomic DNA, the
HDA reaction was repeated at least 6 times. We found that at high
C. difficile DNA concentrations (above 0.125 pg), the limit of
detection for HDA on-chip was comparable to HDA in-tube
reactions. However, as the amount of spiked C. difficile DNA
decreased to 2.561022 pg, the in-tube vs. on-chip results diverged
(Table 1). In the tube reactions, below 2.561022 pg, not all of the
replicates resulted in amplified product. For the chip-based
reactions, this lower limit was 1.2561022 pg. Neither the in-tube
or on-chip HDA reaction could detect C. difficile genomic DNA
below 1023 pg/ml (amount in reaction is 2.561023 pg). Thus, the
disposable DNA amplification platform performed similarly to the
standard tube reactions in this case. In terms of cost, the disposable
platform is capable of providing enough heat, and stable heat for
the reaction for a much lower cost (,$1 US) compared to the
standard tube method where a commercial thermocycler is used as
a heat source.
Discussion
This proof-of-concept study highlights a disposable thermoplas-
tic chip and a heating system that combines a toe-warmer and
Styrofoam to perform the isothermal HDA reaction aimed to
detect the presence of C. difficile in DNA extracted from patient
stool samples. Total incubation time is average of 45 min, which
includes the temperature ramps up to reach 65uC and 30 min
incubation time. In addition to the extraction of DNA by Qiagen
kit, we also showed that a portable device (SNAP) developed in our
lab is able to extract DNA from patient stools without the use of
electrical power. The extracted DNA can be amplified by our
disposable amplification system. The combination of both setups
and low material cost make the protocol promising for further
integration with a direct read-out system for eventual application
in low resource settings.
The HDA reaction often exhibits non-specific amplification as
the reaction reaches steady state, which can sometimes lead to a
long nonspecific product that can be confused with target products
[47]. To avoid this problem we optimized the reaction time to
both amplify the correct product and limit the non-specific
amplification. Via this process, we were able to significantly lower
the background as is evident on the PAGE gels. Recently [48] it
was shown that the HDA reaction time can be decreased to
22 min for the detection of Mycobacterium tuberculosis by optimizing
the primer and the enzyme concentrations. In our case, 30 min
was suitable to amplify DNA extracted from patient stool samples
while limiting background signal. The on-chip reaction does
generate a primer-dimer product of 76 to 90 bp (Figure 6).
Unreacted primers (34, 26 bp) were also visible at an amplification
time of 30 min. Primer-dimers were not seen as often when the
genomic C. difficile DNA and extracted patient stool samples were
amplified in-tube. This result suggests that the undesired primer-
dimer formation may be related to the high surface to volume ratio
environment in the chip. In both the in-tube and on-chip
reactions, primer-dimers sometimes formed in the negative control
reactions (no template). Adding DMSO, adjusting the amount of
MgSO4, and treating COP channel surface with the blocking
agents to prevent enzyme loss to provide lower detection limits and
limit the formation of primer dimers, are other ways to optimize
the amplification assay. In Figure 6, the detection limits of in-tube
vs. on-chip results diverge when the concentration of C. difficile
genomic DNA decreases. This might be a result of chip to chip
variations during the fabrication process. The thermo cycler
method also clearly has the advantage in terms of temperature
control. Also variations in pipetting and sample collecting might
also affect the observed reaction efficiencies at lower concentra-
tions. Not all of the experiments were run on the same day, and
several lot numbers of the HDA enzyme kit were used.
The existing toe warmer-Styrofoam cup setup provides a
constant 65uC62uC for 55 min, which is more than sufficient
for the HDA amplification to occur within the context of a
controlled lab (ambient) environment. All of the data in Figure 2
was obtained under the same ambient conditions. In the field,
ambient conditions can vary widely, and this needs to be taken
into account (i.e. external temperature, humidity) when scaling up
this technology. In our supplemental study, the external temper-
ature (20–40uC) and humidity (2562.5%RH 2 8062.5% RH)
are varied. We found for the same external temperature, the
higher the external humidity, the fewer holes are required to reach
65uC62uC. Also the duration of quasi steady state temperature is
longer. This result is likely due to the fact that when the humidity
is high, there will be more water vapour available. If there are too
many holes, oxidation will occur too quickly to consume the iron,
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thereby decreasing the duration of the steady state regime.
Therefore, an optimum number of holes is important. On one
hand, the holes need to provide enough humidity and O2 to
promote the oxidation. On the other hand, the reaction can
happen too quickly, overheating the enzyme and halting the
reaction. For the same external humidity, the higher the external
Figure 4. Gel electrophoresis analysis of the HDA on-chip amplicons using 12% polyacrylamide gel with MspI digested pBR322 as
marker. (A) five positive human stool DNA samples infected with C. difficile; (B) 3 negative human stool samples; (C) HDA in-tube as a control, and
PCR control reactions to quantify the amount of DNA in the stool extract using human GAPDH as a housekeeping gene.
doi:10.1371/journal.pone.0060059.g004
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temperature, the fewer holes are required to reach 65uC62uC for
the HDA reaction. The higher the temperature, the faster the
reaction. By decreasing the number of holes, less O2 is provided,
and oxidation rate slows down. Our long-term goal is to provide a
cross-reference chart so users can tailor the required airflow to
maintain 65uC62uC for 30 min at different locations ranging
from 20–40uC. As mentioned earlier, there are other electricity
and battery free methods for maintaining constant temperature in
the field. Most notably, phase change materials have been used to
achieve this goal successfully for a number of biochemical assays.
Likely the phase change material approach will be more successful
and reliable than the exothermic reaction method presented here
for many settings, but both are viable for use in the field.
Though we have successfully used the SPE columns without
centrifugation steps with urine, blood and nasowash, stool samples
are a rather special case. They vary greatly in quality, and in order
to obtain suitable analytical samples, often formed stools have to
be used. The centrifuge step is used to prevent the solid stool
particles from clogging the SPE channel. And of course, the
centrifuge is powered. Although it is certainly possible that a
battery or hand powered centrifuge may be suitable for removing
enough particulate to inhibit clogging, we did not do that work
here.
We did however, look at how the device would perform without
any centrifugation step at all. In order to reach the goal of using no
battery or wall power, we tried to eliminate the centrifuge step by
replacing it with filtration. After adding lysis buffer, instead of
using centrifugation to remove the solid particles, the lysate was
filtered by using a filter with 0.2 mm pore size. The stool specimens
may be liquid, soft, semiformed, and formed. For these samples,
especially those formed or semiformed, it is hard to remove the
solid particles by filtration alone. These samples clogged the
column. However, for the samples which are more liquid phase,
we were able to isolate DNA without using centrifuge pre-
extraction step and did amplify that DNA using our toe warmer-
Styrofoam setup (shown in Figure S6). This demonstrates our
nucleic acids extraction procedure can be electricity free if the
sample is liquid phase. Future efforts will focus on making this
device completely electricity free, which might involve several
filtration steps, optimizing pore size of SPE column to avoid the
clogging issue or combining a portable centrifuge.
Although we looked at clinical samples here, it is difficult to
clearly articulate the lower limit of detection (LLOD) for the
clinical case. Little work has been done to assess the molecular
(DNA) LLOD for C. difficile. The lack of LLOD for molecular data
is due to the longstanding use of a protein biomarker for diagnosis
Figure 5. Gel electrophoresis analysis of the HDA on-chip amplicons that was extracted via SNAP.
doi:10.1371/journal.pone.0060059.g005
Table 1. Sensitivity of HDA on-chip reaction vs. in-tube reaction.
C. difficile in 25 ml HDA in-tube HDA on-chip
Conc. (pg/ml) Mass (pg) No. reactions No. positives No. reactions No. positives
50 125 6 6
5 12.5 6 6
0.5 1.25 6 6 6 6
0.1 0.25 6 6
561022 0.125 6 6
161022 2.561022 6 4 (66%) 6 6 (100%)
561023 1.2561022 6 2 (33%) 6 3 (50%)
1023 2.561023 6 0 6 0
doi:10.1371/journal.pone.0060059.t001
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(toxin culture assay). It has been assumed until recently that if one
genome of C. difficile was detectable, then the person should be
considered sick. More recently, as molecular tests have become
available, this assumption is being called into question. It appears
from some studies that a patient can be colonized with C. diffcile,
but not sick. This idea is still controversial among clinicians. Since
it is very difficult to grow the bug in culture, it is not possible to
conduct LLOD tests with stool samples spiked with known
amounts of bug. Thus, we used genomic DNA to achieve this task.
We acknowledge that for this particular organism, there is a gap in
the data in terms of defining a clinically relevant LLOD.
In summary, genomic DNA extracted from patient stool
samples was successfully amplified in the absence of a thermo-
cycler. The previous work [41,42,47] from our group has
demonstrated on-chip extraction of complex biological sample
(e.g. blood, stool) using integrated micro solid phase extraction
(mSPE) columns. Our next challenge will be to design an integrated
cartridge with the capacity to perform DNA extraction from a
stool sample, nucleic acid amplification, and then directly display
the results by simple visual inspection. Since the HDA reaction
only requires one temperature of 65uC, (in contrast to PCR, where
a 95uC step is required), the relatively expensive COP film that has
glass transition temperature of 136uC can be replaced with a less
expensive material like poly(methyl) methacrylate. A low cost
readout using visual inspection has been developed by BioHelix,
and relies on a cassette-based, lateral flow approach to identify C.
difficile [26]. In their method, a lateral flow strip is pre-coated with
two types of antibodies that react with two specific labelled probes
in HDA amplicons respectively to serve as control (C) line and test
(T) line. The amplicon is negative when only C line is visible, and
it is positive when only T line or both the T and C line are visible.
Combining our on chip extraction technology with a visual
readout like the BioHelix platform would yield a very low cost and
robust integrated diagnostic.
Conclusions
We developed a platform composed of a microfluidic chip, toe
warmers and Styrofoam cups to perform isothermal DNA
amplification without electrical power. By punching various
numbers of holes on cup, the amount of supplied air was
controlled so that the desired temperature could be maintained.
The capability of the system to maintain a constant temperature
was investigated. While more holes shortened the time to reach the
steady temperature, the duration of the stable temperature was
decreased. The temperature measurement indicated that a system
with 55 holes can hold 65uC62uC for more than 55 min. By
optimizing the concentration of enzyme and primers, the amount
of time needed for the specific HDA reaction used here as a proof
of concept can be decreased to 30 min, while producing less non-
specific amplicons.
We performed isothermal amplification of DNA extracted from
patient stool samples, and specific identification of C. difficile was
achieved based on HDA for tcdA. The results were consistent with
the gold standard cytotoxicity assays for C. difficile in stool. We also
demonstrated that our disposable platform functions comparably
to a standard method using a thermocycler as a temperature
control with similar detection limits for C. difficile DNA in patient
samples. This work is a step toward the fabrication of an
inexpensive, handheld, point-of-service disposable diagnostic
assay. Continuing work includes integration of on-chip stool
extraction and readout to make a completely handheld device.
Supporting Information
Figure S1 Temperature stability inside the Styrofoam
cups with different numbers of holes under A) 306C and
B) 406C.
(TIF)
Figure S2 HDA in-tube reactions for different total
amplification times: 30, 60, 90 min. Note that primer-
dimers started to form when the reaction is longer than 60 min.
(TIF)
Figure S3 Temperature stability inside the Styrofoam
cups with different numbers of holes at 306C under A)
RH 65±1.5% and B) 80±0.8%.
(TIF)
Figure S4 Temperature stability inside the Styrofoam
cups with different numbers of holes at 406C under A)
RH 58±0.8% and B) 82±0.4%.
(TIF)
Figure S5 Temperature stability inside the Styrofoam
cups with different numbers of holes at 206C under A)
RH 40±0.9% and B) 72±0.6%.
(TIF)
Figure S6 PAGE gel showing SNAP extracted DNA
amplified using the Styrofoam heater without a pre-
centrifugation step. Note that this experiment was only
Figure 6. Sensitivity of HDA on-chip vs. in-tube reaction. HDA mixture with decreasing amounts (125 pg –2.561023 pg) of C. difficile purified
genomic DNA as the template. Then HDA was performed both on-chip (in the power free system) and in-tube (using a thermocycler). The product
yields were compared using PAGE showing the correct size of 110 bp.
doi:10.1371/journal.pone.0060059.g006
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successful for liquid phased stool. Formed and semiformed samples
clogged the SPE columns before extraction was complete.
(TIF)
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